ClinicalTrials.Veeva

Menu

Combination Therapy of Imiquimod 5%Cream and Cryotherapy vs Monotherapy for Common Warts:Randomized Comparative Trial.

A

Assiut University

Status

Not yet enrolling

Conditions

Warts

Study type

Observational

Funder types

Other

Identifiers

NCT06973473
Treatment of common warts

Details and patient eligibility

About

To assess the clinical efficacy and safety of topical imiquimod 5% cream combined with cryotherapy versus either of theme alone for the treatment of common warts by clinical and dermoscopic assessments.

Full description

Topical Imiquimod 5% cream Combined with Cryotherapy Versus either of them alone in Treatment of Common Warts: A prospective Randomized Comparative Trial

Enrollment

60 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients with common warts diagnosed clinically and by dermoscopy.
  • Patients older than 18years old.

Exclusion criteria

  • Pregnancy and lactation.
  • Immunosuppression or being under any kind of treatment causing
  • absolute or relative immunosuppression.
  • Patients with chronic systemic diseases.
  • All cases of bleeding tendency or using anticoagulants.
  • Concurrent use of systemic or topical treatments of warts in the last 4 weeks.

Trial contacts and locations

0

Loading...

Central trial contact

Eman Fathy Ahmed Lecturer of Dermatology, Venereology and Andrology Faculty of

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems